Long-term memory CD8


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
06 09 2022
Historique:
received: 17 01 2022
accepted: 24 08 2022
entrez: 6 9 2022
pubmed: 7 9 2022
medline: 9 9 2022
Statut: epublish

Résumé

Long-term memory T cells have not been well analyzed in individuals vaccinated with a COVID-19 vaccine although analysis of these T cells is necessary to evaluate vaccine efficacy. Here, investigate HLA-A*24:02-restricted CD8

Identifiants

pubmed: 36068240
doi: 10.1038/s41467-022-32989-4
pii: 10.1038/s41467-022-32989-4
pmc: PMC9447987
doi:

Substances chimiques

COVID-19 Vaccines 0
Epitopes, T-Lymphocyte 0
Spike Glycoprotein, Coronavirus 0
Vaccines, Synthetic 0
mRNA Vaccines 0
spike protein, SARS-CoV-2 0
BNT162 Vaccine N38TVC63NU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5251

Informations de copyright

© 2022. The Author(s).

Références

N Engl J Med. 2020 Nov 12;383(20):1920-1931
pubmed: 32663912
Lancet. 2021 May 8;397(10286):1725-1735
pubmed: 33901423
Cell Rep. 2021 Jul 20;36(3):109415
pubmed: 34270919
Nature. 2021 Aug;596(7871):276-280
pubmed: 34237773
Nucleic Acids Res. 2020 Jan 8;48(D1):D783-D788
pubmed: 31722398
Hum Immunol. 2008 Jul;69(7):443-64
pubmed: 18638659
PLoS Pathog. 2021 Dec 2;17(12):e1010022
pubmed: 34855916
Lancet. 2021 May 15;397(10287):1819-1829
pubmed: 33964222
Science. 2021 Dec 03;374(6572):abm0829
pubmed: 34648302
Nature. 2022 Jan;601(7891):110-117
pubmed: 34758478
Nat Med. 2021 Feb;27(2):270-278
pubmed: 33335323
Cell. 2021 Feb 18;184(4):861-880
pubmed: 33497610
Science. 2021 Oct 08;374(6564):eabh1823
pubmed: 34465633
Nucleic Acids Res. 2021 Jan 8;49(D1):D706-D714
pubmed: 33045727
Cell. 2022 Feb 3;185(3):447-456.e11
pubmed: 35026151
Immunity. 2020 Nov 17;53(5):1095-1107.e3
pubmed: 33128877
N Engl J Med. 2021 Aug 12;385(7):664-666
pubmed: 34233096
Lancet. 2020 Aug 15;396(10249):467-478
pubmed: 32702298
Nat Rev Immunol. 2021 Jun;21(6):382-393
pubmed: 33875867
Cell Rep. 2016 Jun 7;15(10):2279-2291
pubmed: 27239036
Nature. 2020 Oct;586(7830):594-599
pubmed: 32998157
Nat Immunol. 2021 Jan;22(1):74-85
pubmed: 32999467
JAMA. 2021 Nov 23;326(20):2043-2054
pubmed: 34734975
Sci Immunol. 2022 Jan 21;7(67):eabk3070
pubmed: 34793243
Cell. 2020 Nov 12;183(4):996-1012.e19
pubmed: 33010815
Med (N Y). 2021 Jun 11;2(6):682-688.e4
pubmed: 33851143
N Engl J Med. 2021 Apr 15;384(15):1412-1423
pubmed: 33626250
Tissue Antigens. 2000 Dec;56(6):522-9
pubmed: 11169242
Nature. 2021 Sep;597(7875):268-273
pubmed: 34320609
Cell Rep Med. 2021 Jul 20;2(7):100354
pubmed: 34250512
Immunogenetics. 1996;44(4):233-41
pubmed: 8753852
Mil Med Res. 2021 Aug 31;8(1):47
pubmed: 34465396
Sci Immunol. 2020 Jun 26;5(48):
pubmed: 32591408
Nat Med. 2022 Mar;28(3):481-485
pubmed: 35051990
Cell Rep. 2021 Feb 9;34(6):108728
pubmed: 33516277
N Engl J Med. 2021 Dec 9;385(24):e84
pubmed: 34614326
Cell Rep. 2022 Jan 11;38(2):110235
pubmed: 34986327
Nature. 2020 Oct;586(7830):589-593
pubmed: 32785213
Lancet Microbe. 2022 Jan;3(1):e21-e31
pubmed: 34778853
Science. 2021 Oct 22;374(6566):eabj9853
pubmed: 34519540
Nat Med. 2021 Jun;27(6):1062-1070
pubmed: 33888900
Cell. 2022 Mar 3;185(5):847-859.e11
pubmed: 35139340
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Commun Biol. 2021 Dec 2;4(1):1365
pubmed: 34857854
Immunogenetics. 1993;37(2):139-42
pubmed: 8423053
JAMA. 2021 Aug 24;326(8):728-735
pubmed: 34251417
Lancet. 2020 Jun 13;395(10240):1845-1854
pubmed: 32450106
J Clin Invest. 2021 Mar 1;131(5):
pubmed: 33427749
N Engl J Med. 2020 Dec 17;383(25):2427-2438
pubmed: 32991794
Tissue Antigens. 2015 Apr;85(4):252-9
pubmed: 25789826
Nature. 2022 Mar;603(7901):493-496
pubmed: 35102312
Lancet Reg Health Eur. 2021 Nov;10:100208
pubmed: 34514454
Clin Infect Dis. 2022 May 3;74(9):1515-1524
pubmed: 34358310
Cell. 2022 Feb 3;185(3):457-466.e4
pubmed: 34995482
Cell Rep Med. 2021 Apr 20;2(4):100255
pubmed: 33842902
Cell Rep. 2021 Sep 14;36(11):109708
pubmed: 34506741
J Virol. 2014 May;88(9):4764-75
pubmed: 24522911
Cell Host Microbe. 2021 Jul 14;29(7):1124-1136.e11
pubmed: 34171266
Nature. 2021 Nov;599(7883):114-119
pubmed: 34488225
Cell Rep Med. 2021 Feb 16;2(2):100204
pubmed: 33521695
Cell Host Microbe. 2021 Jul 14;29(7):1076-1092
pubmed: 34237248
Immunol Cell Biol. 2021 Oct;99(9):990-1000
pubmed: 34086357
N Engl J Med. 2020 Dec 17;383(25):2439-2450
pubmed: 33053279
Nature. 2021 Jul;595(7868):572-577
pubmed: 34044428
Cell. 2022 Feb 17;185(4):603-613.e15
pubmed: 35026152
N Engl J Med. 2021 Jul 22;385(4):320-329
pubmed: 34192428

Auteurs

Nozomi Kuse (N)

Division of International Collaboration Research and Tokyo laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto/Tokyo, Japan.

Yu Zhang (Y)

Division of International Collaboration Research and Tokyo laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto/Tokyo, Japan.

Takayuki Chikata (T)

Division of International Collaboration Research and Tokyo laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto/Tokyo, Japan.

Hung The Nguyen (HT)

Division of International Collaboration Research and Tokyo laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto/Tokyo, Japan.

Shinichi Oka (S)

Division of International Collaboration Research and Tokyo laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto/Tokyo, Japan.
AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.

Hiroyuki Gatanaga (H)

Division of International Collaboration Research and Tokyo laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto/Tokyo, Japan.
AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.

Masafumi Takiguchi (M)

Division of International Collaboration Research and Tokyo laboratory, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto/Tokyo, Japan. masafumi@kumamoto-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH